1 January 2020 in Brain Research
1 March 2020 in Annals of Translational Medicine
Background: Glioblastoma multiforme (GBM) is the most common primary brain tumor, and is associated with a poor prognosis. Hypoxia is prevalent in the microenvironment of GBM, and promotes tumorigenesis and resistance to anticancer therapy. However, its mechanism remains incompletely understood. Methods: We used immunohistochemistry, quantitative real-time PCR, and Western blots to assess c-Myc and Rab7a expression levels in 12 GBM specimens from a single institution. A luciferase reporter assay was conducted to confirmed whether Rab7a is transcriptionally regulated by c-Myc. To clarify the precise role of c-Myc/Rab7a on GBM cell proliferation, we did in vitro and in vivo analyses with lentivirus vectors. Cell viability was assessed using a cell counting kit-8 assay in the context of hypoxia. Autophagy was measured using transmission electron microscopy and Western blot, and apoptosis was measured using flow cytometry and Western blot. Results: Gene and protein expression of c-Myc and Rab7a were significantly upregulated in GBM specimens. Moreover, c-Myc regulated Rab7a by specifically interacting with the Rab7a promoter. Furthermore, hypoxia activated the c-Myc/Rab7a pathway, which protects GBM cells from damage caused by hypoxia. Importantly, c-Myc/Rab7a inhibited apoptosis and induced autophagy in vitro and in vivo. Conclusions: Collectively, our results suggest that the c-Myc/Rab7a pathway protects GBM cells from hypoxic injury via regulation of apoptosis and autophagy, contributing to the growth of GBM.
12 January 2026 in Neuro-Oncology Advances
Surgical resection is controversial in treating primary central nervous system lymphoma (PCNSL). This study aimed to elucidate the prognostic role of resection based on treatment- and survival-related tumor localizations. Magnetic resonance imaging (MRI) data of 122 untreated PCNSL patients from January 2007 to October 2021 were analyzed. Images were registered to a standard anatomical template, followed by lesion segmentation. Analysis of differential involvement (ADIFFI) identified statistically significant voxel-wise clusters using P-value heatmaps. Overall survival (OS) and progression-free survival (PFS) were evaluated via Kaplan-Meier analyses. Multivariate Cox regression was performed to identify independent prognostic factors. Favorable but non-significant trends for OS and PFS were detected in patients receiving resection compared to biopsy. ADIFFI revealed that clusters in superficial frontal and parietal areas were more likely to receive resection, whereas deep-seated clusters were more inclined to be biopsied. Superficial localization also predominated in patients with OS > 2 years, suggesting the spatial confounding effect. Crucially, by controlling for the dual confounders of tumor location and age, significantly prognostic advantages for resection over biopsy were identified in patients with superficial PCNSLs aged ≤ 70 years. Further Cox regression in this subgroup demonstrated that surgical resection, particularly gross total resection, emerged as an independent protective factor for OS. The historically perceived limited benefit of resection in PCNSL may be confounded by tumor localization and patient age. For selected patients with superficial lesions aged ≤ 70 years, resection appears to provide survival advantages, offering a reference to refine surgical decision-making.